Ana Santos Rutschman
Professor of Law
Faculty Director, Health Innovation Lab
Biography
Ana Santos Rutschman, professor of law, teaches and researches topics related to health law, intellectual property, innovation in the life sciences and law and technology. She is a nationally and internationally recognized expert on vaccine law and policy, the regulation of emerging health technologies and access to medicines. At Villanova, Rutschman is the founder and director of the Health Innovation Lab, an interdisciplinary platform that brings together academic researchers, students, policymakers, practitioners, industry and the Philadelphia and Northeast Corridor communities.
Rutschman’s work has been recognized by numerous institutions, including the American Society of Law Medicine & Ethics, which named her a Health Law Scholar in 2018 and Bio Intellectual Property Scholar in 2017. In 2018, she was also named a Wiet Life Sciences Law Scholar by the Beazley Institute for Health Law and Policy at Loyola University Chicago. In 2022, the Boston Congress of Public Health selected her as one of the inaugural recipients of a 40 Under 40 Public Health Catalyst Award for her work on vaccine law and policy.
Rutschman’s book, Vaccines as Technology: Innovation, Barriers and the Public Health, was published in 2022 by Cambridge University Press. Her legal scholarship has appeared or is forthcoming in UCLA Law Review, Emory Law Journal, Indiana Law Journal, UC Davis Law Review, Arizona Law Review, Yale Law Journal Forum, Harvard Public Health Review and Vanderbilt Journal of Transnational Law, among several others. Her peer-reviewed work has appeared in Nature Biotechnology, Vaccine, Emerging Infectious Diseases and American Journal of Infection Control, among others. Her commentary pieces have been published by Health Affairs Blog, Bill of Health, Saint Louis Post-Dispatch, the Huffington Post and The Conversation, and republished in Scientific American, Newsweek Japan and numerous US newspapers.
Before joining Villanova Law in 2022, Rutschman taught in the health law program at Saint Louis University School of Law (2018-2022) and served as the inaugural Jaharis Fellow in Health Law and Intellectual Property at DePaul University College of Law in Chicago (2016-2018). Rutschman has also consulted for the World Health Organization (in 2022 and 2015-2016) on matters related to the development of drugs and vaccines against COVID-19, Zika and Ebola.
Practice Experience
- Consultant, World Health Organization (2022; 2015-2016)
- Joined the faculty in 2022
Recent Publications
-
Impact of the 23andMe Bankruptcy on Preserving the Public Benefit of Scientific Data, Nature Genetics, December 2025
-
Mapping Intellectual Property Abuses in the Pharmaceutical Field, JAMA Health Forum, November 2025
-
The New Vaccine Federalism in the US, Health Affairs Forefront, October (4th Quarter/Autumn) 2025
-
The American Asthma Patient, UC Davis Law Review, March 2025
-
Vaccine Patent Pledges in the Intellectual Property Context, Bloomberg Law, August 2024
Recent Presentations
-
'Colloquium in Law and Biomedical Sciences', University of Utah S.J. Quinney College of Law , February 2026
-
'Health Law Workshop', Harvard Law School, September 2025
-
'International Conference on Emerging Issues in IP Law', Salzburg University, September 2025
-
'National Vaccine Law Conference Annual Meeting', National Vaccine Law Conference, September 2025
-
'Wiet Life Sciences Law Scholars Conference', Loyola University of Chicago School of Law , September 2025
Office: Rm 228, John F. Scarpa Hall
Phone: 610-519-5291
Courses and Seminars
- Health Care and the Law
- Regulation of Emerging Health Tech: From AI to 3D Printing
- FDA Law and Policy
- Health and IP
- Contracts
Education
- Duke University School of Law, SJD
- Duke University School of Law, LLM
- Catholic University of Portugal, LLM (International Trade and Business)
- Catholic University of Portugal, JD
